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Abstract:
The Galanin N-terminal fragment (1-15) [GAL(1-15)] induces depressant- and
anxiogenic-like actions in behavioral tests and these effects were significantly
stronger than the ones induced by Galanin. Since anhedonia is a core feature of
depression, we have analyzed GAL(1-15) actions in two anhedonic-like behavior
tests: saccharin Self-administration and Sucrose Preference test (SPT). In order to
investigate whether the effect of GAL(1-15) was associated with the reward circuit, we
have studied the GAL(1-15) actions over the mesolimbic system by the expression of
the C-Fos, Dat, Vmat2 and Dopamine and GAL receptors genes in VTA and NAc.
Three sets of experiments were conducted in the saccharin Self-administration test.
In the first, a dose-response curve of GAL(1-15) 1nmol, 3nmol or vehicle was
performed. We have also compared the effects in the number of saccharine
reinforcements of GAL 3nmol and GAL(1-15) 3nmol. In the last experiments, rats
received i.c.v. GAL(1-15) 3nmol and the GALR2 antagonist M871 3nmol. In SPT, we
have analyzed the effects of GAL(1-15) 3nmol in the sucrose intake and preference
after 2, 8 and 24 h. In the qPCR experiments, groups of rats were killed 1h after i.c.v.
GAL(1-15) 3nmol or vehicle. The VTA and NAc were dissected and the mRNA
expression of C-Fos, Dat, Vmat2 and D1, D2, D3, D5, GALR1, and GALR2 receptors
were measured. GAL(1-15) 3nmol significantly decreased the number of
reinforcement of saccharin self-administer (p<0.01), while 1nmol lacked effect.
GAL(1-15) also significantly reduced the number of reinforcement (p<0.01)
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compared with GAL. The GALR2 antagonist M871 significantly blocked (p<0.05) the
decrease in the number of saccharin reinforcements induced by GAL(1-15). In the
SPT, GAL(1-15) decreased the sucrose intake 8 (p<0.05) and 24 hours (p<0.01) after
administration. GAL(1-15) at a dose of 3 nmol produced a significant decrease in the
mRNA levels of Dat and Vmat2 (p<0.05) and an increase in the D3 receptor (p<0.05)
in VTA. In the NAc, GAL(1-15) induced a significant decrease in the expression of
C-Fos (p<0.05) mRNA and a significantly increased the mRNA expression of D1
(p<0.05), D2 (p<0.05) and D3 (p<0.05). In the current study, we described for the
first time that GAL(1-15) induced a strong anhedonia-like phenotype in several
behavioral tests, confirming an important role of this neuropeptide in anhedonia,
moreover, the dopaminergic mesolimbic system was described as a key region in
GAL(1-15)-mediated action on anhedonia. These results may give the basis for the
development of novel therapeutic strategies using GAL(1-15) for treatment of
depression and reward-related diseases.
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